{"id":"NCT00510068","sponsor":"Novartis Pharmaceuticals","briefTitle":"Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors","officialTitle":"A Randomized Double-blind Phase III Study of RAD001 10 mg/d Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Pancreatic Neuroendocrine Tumor (NET)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-07","primaryCompletion":"2010-02","completion":"2014-03","firstPosted":"2007-08-01","resultsPosted":"2011-12-15","lastUpdate":"2015-07-01"},"enrollment":410,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Advanced Neuroendocrine Tumors of Pancreatic Origin"],"interventions":[{"type":"DRUG","name":"Everolimus","otherNames":["RAD001"]},{"type":"DRUG","name":"Everolimus Placebo","otherNames":[]}],"arms":[{"label":"Everolimus 10 mg/day","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study was to evaluate progression free survival in those participants assigned everolimus 10 mg/day plus Best Supportive Care versus those assigned to placebo plus Best Supportive Care in Advanced Neuroendocrine Tumors of pancreatic origin.","primaryOutcome":{"measure":"Time to Progression Free Survival (PFS) Based as Per Investigator Using Kaplan-Meier Methodology","timeFrame":"Time from randomisation to dates of disease progression, death from any cause or last tumor assessment, reported between day of first patient randomised, 17 August 2007, until cut-off date 28 February 2010","effectByArm":[{"arm":"Everolimus 10 mg/Day","deltaMin":11.04,"sd":null},{"arm":"Placebo","deltaMin":4.6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":82,"countries":["United States","Belgium","Brazil","Canada","France","Germany","Greece","Italy","Japan","Netherlands","Slovakia","South Korea","Spain","Sweden","Switzerland","Taiwan","Thailand","United Kingdom"]},"refs":{"pmids":["33560090","28113028","27621394","25479584","21306238"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":84,"n":204},"commonTop":["Stomatitis","Diarrhoea","Rash","Fatigue","Nausea"]}}